Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients. A pilot study

Transplantation. 1994 Sep 15;58(5):625-8. doi: 10.1097/00007890-199409150-00018.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial

MeSH terms

  • Adult
  • Alanine Transaminase / metabolism
  • Aspartate Aminotransferases / metabolism
  • Dose-Response Relationship, Drug
  • Female
  • Follow-Up Studies
  • Hepatitis C / complications
  • Hepatitis C / drug therapy*
  • Hepatitis C / enzymology
  • Humans
  • Interferon Type I / adverse effects
  • Interferon Type I / therapeutic use*
  • Kidney Transplantation*
  • Male
  • Middle Aged
  • Pilot Projects
  • Recombinant Proteins
  • gamma-Glutamyltransferase / metabolism

Substances

  • Interferon Type I
  • Recombinant Proteins
  • gamma-Glutamyltransferase
  • Aspartate Aminotransferases
  • Alanine Transaminase